1 week Ago By Defense World Staff
Clover Health Investments, Corp. ( NASDAQ:CLOV – Get Free Report ) reached a new 52-week high during trading on Friday . The company traded as high as $4.
73 and last traded at $4.68, with a volume of 1022951 shares trading hands. The stock had previously closed at $4.
68. Analysts Set New Price Targets CLOV has been the subject of several research reports. UBS Group began coverage on Clover Health Investments in a research report on Monday, October 7th.
They issued a “neutral” rating and a $4.00 target price for the company. Craig Hallum started coverage on Clover Health Investments in a research note on Tuesday, December 17th.
They set a “buy” rating and a $6.00 price objective on the stock. Check Out Our Latest Report on Clover Health Investments Clover Health Investments Stock Performance Clover Health Investments ( NASDAQ:CLOV – Get Free Report ) last issued its quarterly earnings results on Wednesday, November 6th.
The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.03) by $0.
01. Clover Health Investments had a negative return on equity of 25.46% and a negative net margin of 5.
92%. The firm had revenue of $330.99 million during the quarter, compared to analyst estimates of $347.
60 million. During the same period last year, the company posted ($0.09) EPS.
Sell-side analysts predict that Clover Health Investments, Corp. will post -0.12 EPS for the current year.
Institutional Investors Weigh In On Clover Health Investments Several large investors have recently modified their holdings of CLOV. Ballentine Partners LLC purchased a new stake in Clover Health Investments during the fourth quarter valued at about $131,000. SignalPoint Asset Management LLC lifted its position in shares of Clover Health Investments by 6.
2% in the 4th quarter. SignalPoint Asset Management LLC now owns 160,074 shares of the company’s stock valued at $504,000 after acquiring an additional 9,390 shares in the last quarter. Steph & Co.
boosted its stake in Clover Health Investments by 33.3% in the 4th quarter. Steph & Co.
now owns 20,000 shares of the company’s stock worth $63,000 after purchasing an additional 5,000 shares during the period. Graypoint LLC purchased a new position in Clover Health Investments during the 4th quarter worth approximately $632,000. Finally, Silverleafe Capital Partners LLC grew its position in Clover Health Investments by 182.
9% during the 4th quarter. Silverleafe Capital Partners LLC now owns 45,000 shares of the company’s stock worth $142,000 after purchasing an additional 29,091 shares in the last quarter. 19.
77% of the stock is owned by institutional investors. About Clover Health Investments ( Get Free Report ) Clover Health Investments, Corp. provides medicare advantage plans in the United States.
It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Recommended Stories Five stocks we like better than Clover Health Investments The 3 Best Retail Stocks to Shop for in August Bloom Energy: Powering the Future With Decentralized Energy What is the Nikkei 225 index? Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul Are These Liquid Natural Gas Stocks Ready For An Upside Bounce? Why Traders Are Buying the Dip on Johnson & Johnson Stock Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.
com's FREE daily email newsletter ..
